SCHEMBL28689804

SCHEMBL28689804

CCN(c1ccc(-c2cccc3cnc(Nc4cccc(N5CCN(C(C)=O)CC5)c4)nc23)cc1)[SH](=O)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.56
▸ CDK1 P06493 5/20 0.48
▸ CCNB1 P14635 5/20 0.48
▸ JAK2 O60674 4/20 0.48
▸ BRD4 O60885 3/20 0.48
▸ FLT3 P36888 3/20 0.48
▸ CDK2 P24941 9/20 0.48
▸ CCNT1 O60563 8/20 0.48
▸ CCNA2 P20248 8/20 0.48
▸ CDK9 P50750 8/20 0.48
▸ JAK3 P52333 2/20 0.47
▸ CDK7 P50613 4/20 0.46
▸ CCNH P51946 4/20 0.46
▸ FGFR2 P21802 1/20 0.46
▸ JAK1 P23458 1/20 0.46
▸ CCNA1 P78396 2/20 0.45
▸ MAP3K7 O43318 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ MAP2K1 Q02750 1/20 0.44
▸ CCNE1 P24864 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28686752 0.91 EGFR (0.53) EGFRCDK1CCNB1JAK2BRD4
SCHEMBL28931694 0.90 EGFR (0.58) EGFRCDK1CCNB1JAK2BRD4
SCHEMBL28695538 0.88 TBK1 (0.49) EGFRJAK2BRD4JAK3FGFR2
SCHEMBL29368834 0.85 EGFR (0.62) EGFRCDK1CCNB1JAK2BRD4
SCHEMBL18376840 0.85 EGFR (0.62) EGFRCDK1CCNB1JAK2BRD4
SCHEMBL18377056 0.85 EGFR (0.60) EGFRCDK1CCNB1JAK2BRD4
SCHEMBL28120647 0.85 EGFR (0.60) EGFRCDK1CCNB1JAK2BRD4
SCHEMBL18376844 0.84 EGFR (0.65) EGFRCDK1CCNB1JAK2BRD4
SCHEMBL28693201 0.84 EGFR (0.55) EGFRCDK1CCNB1JAK2BRD4
SCHEMBL18376777 0.84 EGFR (0.60) EGFRCDK1CCNB1JAK2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 — — CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 — — CN disclosed
Send feedback